BRPI1008743A2 - Processo para o preparo de olopatadina e/ou um sal farmacêuticamente aceitável da mesma. - Google Patents

Processo para o preparo de olopatadina e/ou um sal farmacêuticamente aceitável da mesma.

Info

Publication number: BRPI1008743A2
Authority: BR; Brazil
Prior art keywords: pharmaceutically acceptable; acceptable salt; preparing olopatadine; olopatadine; preparing
Prior art date: 2009-02-05

Application number

BRPI1008743-5A

Other languages

English (en)

Inventor

Alberto Guidi

Gianmauro Orru

Massimo Verzini

Livius Cotarca

Jean-Claude Kizirian

Elisenda Trepat Guixer

Francisco Marquillas Olondriz

Original Assignee

Zach System Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-05

Filing date

2010-02-01

Publication date

2015-09-01

2010-02-01 Application filed by Zach System Spa filed Critical Zach System Spa

2015-09-01 Publication of BRPI1008743A2 publication Critical patent/BRPI1008743A2/pt

2017-07-11 Publication of BRPI1008743A8 publication Critical patent/BRPI1008743A8/pt

2021-09-08 Publication of BRPI1008743B1 publication Critical patent/BRPI1008743B1/pt

Links

238000004519 manufacturing process Methods 0.000 title 1
JBIMVDZLSHOPLA-LSCVHKIXSA-N olopatadine Chemical compound C1OC2=CC=C(CC(O)=O)C=C2C(=C/CCN(C)C)\C2=CC=CC=C21 JBIMVDZLSHOPLA-LSCVHKIXSA-N 0.000 title 1
229960004114 olopatadine Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/12—[b,e]-condensed
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pulmonology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Otolaryngology (AREA)
Immunology (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyrane Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BRPI1008743-5A 2009-02-05 2010-02-01 Processo para o preparo de olopatadina BRPI1008743B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP09152194.8		2009-02-05
EP09152194		2009-02-05
PCT/EP2010/051148 WO2010089268A2 (en)	2009-02-05	2010-02-01	Process for preparing olopatadine and/or a pharmaceutically acceptable salt thereof

Publications (3)

Publication Number	Publication Date
BRPI1008743A2 true BRPI1008743A2 (pt)	2015-09-01
BRPI1008743A8 BRPI1008743A8 (pt)	2017-07-11
BRPI1008743B1 BRPI1008743B1 (pt)	2021-09-08

Family

ID=42109900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1008743-5A BRPI1008743B1 (pt)	2009-02-05	2010-02-01	Processo para o preparo de olopatadina

Country Status (14)

Country	Link
US (1)	US8835655B2 (pt)
EP (1)	EP2393797B1 (pt)
JP (1)	JP5564060B2 (pt)
CN (1)	CN102292326B (pt)
AU (1)	AU2010211085B2 (pt)
BR (1)	BRPI1008743B1 (pt)
CA (1)	CA2746331C (pt)
ES (1)	ES2581833T3 (pt)
HR (1)	HRP20160567T1 (pt)
HU (1)	HUE028705T2 (pt)
IL (1)	IL213364A (pt)
PL (1)	PL2393797T3 (pt)
SI (1)	SI2393797T1 (pt)
WO (1)	WO2010089268A2 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2014147647A1 (en)	2013-03-19	2014-09-25	Council Of Scientific & Industrial Research	A process for the synthesis of olopatadine
CN106117176B (zh) *	2016-06-24	2018-12-11	四川大学	二氢双苯并恶庚衍生物及其组合物与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4282365A (en) *	1978-11-24	1981-08-04	Merck & Co., Inc.	Dibenz[b,e]oxepin compounds
EP0069810B1 (en)	1981-07-09	1986-12-03	Merck & Co. Inc.	Novel dibenzoxepins, their preparation, compositions containing them and the use of dibenzoxepins in the treatment of allergic conditions
GB8520662D0 (en)	1985-08-17	1985-09-25	Wellcome Found	Tricyclic aromatic compounds
JPS6310784A (ja)	1986-03-03	1988-01-18	Kyowa Hakko Kogyo Co Ltd	抗アレルギー剤
BRPI0512732A (pt) *	2004-06-28	2008-04-08	Alcon Inc	formulações tópicas para tratamento de doenças alérgicas
ES2253996B1 (es)	2004-07-28	2007-08-16	Urquima, S.A.	Procedimiento para la preparacion del acido 11-((z)-3-(dimetilamino)propiliden)-6,11-dihidrodibenz(b,e)oxepinacetico.
CA2634665A1 (en)	2005-12-22	2007-10-25	Medichem, S.A.	Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
US7687646B2 (en) *	2006-03-28	2010-03-30	Azad Pharmaceutical Ingredients, Ag	Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof

2010
- 2010-02-01 WO PCT/EP2010/051148 patent/WO2010089268A2/en not_active Ceased
- 2010-02-01 CN CN201080005022.7A patent/CN102292326B/zh active Active
- 2010-02-01 US US13/147,741 patent/US8835655B2/en active Active
- 2010-02-01 EP EP10705320.9A patent/EP2393797B1/en active Active
- 2010-02-01 HR HRP20160567TT patent/HRP20160567T1/hr unknown
- 2010-02-01 AU AU2010211085A patent/AU2010211085B2/en active Active
- 2010-02-01 ES ES10705320.9T patent/ES2581833T3/es active Active
- 2010-02-01 CA CA2746331A patent/CA2746331C/en active Active
- 2010-02-01 JP JP2011548657A patent/JP5564060B2/ja active Active
- 2010-02-01 BR BRPI1008743-5A patent/BRPI1008743B1/pt active IP Right Grant
- 2010-02-01 HU HUE10705320A patent/HUE028705T2/en unknown
- 2010-02-01 SI SI201031206A patent/SI2393797T1/sl unknown
- 2010-02-01 PL PL10705320.9T patent/PL2393797T3/pl unknown
2011
- 2011-06-05 IL IL213364A patent/IL213364A/en active IP Right Grant

Also Published As

Publication number	Publication date
AU2010211085A1 (en)	2011-07-07
CN102292326A (zh)	2011-12-21
US8835655B2 (en)	2014-09-16
BRPI1008743B1 (pt)	2021-09-08
PL2393797T3 (pl)	2016-12-30
CN102292326B (zh)	2015-04-22
BRPI1008743A8 (pt)	2017-07-11
WO2010089268A2 (en)	2010-08-12
WO2010089268A3 (en)	2010-10-14
HUE028705T2 (en)	2016-12-28
EP2393797B1 (en)	2016-04-20
CA2746331A1 (en)	2010-08-12
AU2010211085B2 (en)	2016-08-25
HRP20160567T1 (hr)	2016-07-01
EP2393797A2 (en)	2011-12-14
JP5564060B2 (ja)	2014-07-30
US20120016138A1 (en)	2012-01-19
CA2746331C (en)	2016-09-06
JP2012516869A (ja)	2012-07-26
IL213364A (en)	2016-06-30
ES2581833T3 (es)	2016-09-07
SI2393797T1 (sl)	2016-07-29
IL213364A0 (en)	2011-07-31

Similar Documents

Publication	Publication Date	Title
NO2022033I1 (no)	2022-07-22	Rimegepant or a pharmaceutically acceptable salt thereof
NO2023047I1 (no)	2023-12-21	Cedazuridine, or a pharmaceutically acceptable salt thereof
HUS000500I2 (hu)	2021-03-29	Upadacitinib vagy gyógyszerészetileg elfogadható sója
NO2020034I1 (no)	2020-09-29	Ozanimod eller et farmasøytisk akseptabelt salt derav, særlig ozanimodhydroklorid
NO2020038I1 (no)	2020-11-18	Ozanimod, or a pharmaceutically acceptable salt thereof, including the hydrochloride salt
BRPI0910734A2 (pt)	2015-09-29	composto, composição farmacêutica, e, processo para preparar um composto ou um sal farmaceuticamente aceitável do mesmo.
BRPI0919018A2 (pt)	2015-12-08	sal farmaceuticamente aceitável, uso de sal, e, processo para a preparação de sal
NO2015012I1 (no)	2015-05-04	Ombitasvir, eller et farmasøytisk akseptabelt salt derav
NL300886I2 (nl)	2017-10-24	baricitinib, of een farmaceutisch aanvaardbaar zout daarvan
NO2016016I1 (no)	2016-08-17	Lesinurad, eller et farmasøytisk akseptabelt salt derav
BRPI1013561A8 (pt)	2015-09-22	processo para a preparação de alogliptina
BRPI0918038A2 (pt)	2015-08-04	Processos para preparar um composto e um sal, e, composto
BRPI1014606A2 (pt)	2015-08-25	Maltotriosil transferase, processo para produção e uso da mesma
BRPI1004574A2 (pt)	2018-02-06	pastilha de corte com fornecimento de refrigerante e método para a elaboração da pastilha de corte
NO2023002I1 (no)	2023-01-05	Lasmiditan or a pharmaceutically acceptable salt thereof
BRPI0813284A2 (pt)	2014-12-30	Processos para a preparação de pirazóis
BRPI1014547A2 (pt)	2016-04-05	composto, e, processo para preparar um composto.
BRPI0923007A2 (pt)	2015-08-11	Sal de piperazina e um processo para preparação do mesmo
BRPI0924566A2 (pt)	2016-08-30	sistema para cirurgia oftálmica a laser
BRPI1013032A2 (pt)	2019-09-24	"película de barreira resistente às intempéries, processo para a produção desta e uso da mesma"
BRPI1014691A2 (pt)	2015-08-25	Composto, e, processo para a preparação de um composto.
BRPI0922836A2 (pt)	2016-10-18	processo para a preparação de um sal de succinato monovalente
BRPI1010300A2 (pt)	2017-05-16	processos para a preparação de um composto, para perparar dronedarone, ou um sal do mesmo, e para preparar uma formulação farmacêutica.
BRPI1015089A2 (pt)	2016-04-26	nifuratel ou um sal fisiologicamente aceitável do mesmo.
BRPI1009816A2 (pt)	2015-08-25	"método para preparar um composto."

Legal Events

Date	Code	Title	Description
2017-07-11	B25A	Requested transfer of rights approved	Owner name: F.I.S. - FABBRICA ITALIANA SINTETICI S.P.A. (IT)
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2018-11-21	B06T	Formal requirements before examination [chapter 6.20 patent gazette]
2020-06-09	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2021-03-09	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2021-03-16	B15K	Others concerning applications: alteration of classification	Free format text: A CLASSIFICACAO ANTERIOR ERA: C07D 313/12 Ipc: C07D 313/12 (2006.01), A61P 11/02 (2006.01), A61P
2021-03-30	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-07-06	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-08-24	B09X	Republication of the decision to grant [chapter 9.1.3 patent gazette]
2021-09-08	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 01/02/2010, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.